BAYER AG |
Market Closed -
Other stock markets
|
After market 03:05:15 pm | |||
| 27.35 EUR | -0.87% |
|
27.35 | +0.01% |
| 01:02pm | Bayer: strategic collaboration with Evotec | CF |
| 11:52am | Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies | MT |
Presenter SpeechNorbert Winkeljohann (Executives)Ladies and gentlemen, as Chairman of the Supe...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
2024-05-14
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
27.59
EUR
Average target price
36.9
EUR
Spread / Average Target
+33.76%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -18.67% | 29.04B | |
| +33.86% | 664B | |
| +29.29% | 567B | |
| -7.45% | 354B | |
| +18.83% | 330B | |
| +4.56% | 286B | |
| +13.79% | 234B | |
| +4.93% | 199B | |
| -9.78% | 196B | |
| -4.85% | 148B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Transcript : Bayer Aktiengesellschaft - Shareholder/Analyst Call
